Medical imaging software provider MeVis Medical Solutions is in talks with NHS England about how the company’s Veolity software can help in the roll out of the NHS’s lung health check programme.
The NHS scheme aims to use a low-dose computed tomography (CT) scan on 600,000 at-risk individuals over the next four years to detect early signs of lung cancer.
Go deeper with GlobalData
Veolity, which is distributed in the UK by content management organisation SynApps Solutions, helps to identify, segment and calculate the proportions and make-up of pulmonary nodules in individuals’ scans.
The platform combines computer aided detection (CAD) of solid pulmonary nodules, integration and automatic registration of prior case studies to generate reports about individual patients.
Radiology teams can use Veolity to perform an automated first review of a patient’s scans, including current-prior comparisons. The CAD findings can alert a radiologist to areas of interest that may have been initially overlooked.
Eight NHS trusts are currently in discussions to deploy Veolity as part of the nationwide lung health check programme, sparked by the success of a 2016 trial run through the University Hospital of South Manchester Trust (UHSM).
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataUHSM offered smokers and ex-smokers aged 55-74 across 14 participating GP practices a ‘Lung Health Check’ consisting of a spirometry and a low-dose CT scan for patients considered high-risk.
Over 2,500 people were checked, with 46 incidences of lung cancer detected across 42 patients. Almost 90% of these diagnoses were made at a stage early enough to receive curative treatment.
The programme is now being rolled out across the country in a drive to save lives by catching lung cancer early.
The increased workload this will generate for radiologists can be managed through the Veolity platform, enabling them to interpret and validate high volumes of new lung scan results within an acceptable timeframe.
SynApps co-founder and chief technology officer Jason Scholes said: “A radiologist performing 10 lung studies per day could gain back two hours of their time, by using the software. With the shortage of trained radiologists, having access to tools that can help process workloads more swiftly, while maintaining high accuracy of analysis, is vital.”
Lung cancer is the most common cancer worldwide and is the largest single cause of cancer deaths each year.
